Table 3.
Category | Scoring elements | Results | Points |
---|---|---|---|
Autoantibodies | ANA or SMA | 1:40 by IIF | +1 |
ANA or SMA | ≥1:80 by IIF | +2 | |
Anti-LKM1 (alternative to ANA and SMA) | ≥1:40 by IIF | +2 | |
Anti-SLA (alternative to ANA, SMA and LKM1) | Positive | +2 | |
Immunoglobulins | Immunoglobulin G level | >ULN | +1 |
>1.1 times ULN | +2 | ||
Histological findings | Interface hepatitis | Compatible features | +1 |
Typical features | +2 | ||
Viral markers | IgM anti-HAV, HBsAg, HBV DNA, HCV RNA | No viral markers | +2 |
Probable diagnosis | ≥6 | ||
Definite diagnosis | ≥7 |
ANA, antinuclear antibodies; SMA, smooth muscle antibodies; anti-LKM1, antibodies to liver kidney microsome type 1; SLA, soluble liver antigen; IIF, indirect immunofluorescence; ULN, upper limit of the normal range; IgM, immunoglobulin M; HAV, hepatitis A virus; HBsAg, hepatitis B surface antigen; HBV, hepatitis B virus; DNA, deoxyribonucleic acid; HCV, hepatitis C virus; RNA, ribonucleic acid.
Adapted from Hennes EM, et al. Hepatology 2008;48:169–176, with the permission of John Wiley & Sons, Inc. and the American Association for the Study of Liver Disease.20